Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and Vaccines.

导出 OA

翻译打印收藏纠错

作者： Matthew E,Popkin ^[1] ; Markus,Goese ^[2] ; Diane,Wilkinson ^[3] ; Stuart,Finnie ^[4] ; Talia,Flanagan ^[5] ; Cristiana,Campa ^[6] ; Alexandra,Clinch ^[7] ; Andrew,Teasdale ^[8] ; Andrew,Lennard ^[9] ; Graham,Cook ^[10] ; Ganapathy,Mohan ^[11] ; Matthew D,Osborne ^[12]

作者单位： GSK, David Jack Centre for R&D, Park Road, Ware, SG12 0DP, UK. ^[1] F. Hoffmann-La Roche Ltd, CH-4070, Basel, Switzerland. ^[2] AstraZeneca, Derwent Building, Silk Road Business Park, Charter Way, Macclesfield, SK10 2NA, UK. ^[3] AstraZeneca, Charter Way, Macclesfield, SK10 2NA, UK. ^[4] UCB Pharma SA, 1420, Braine l'Alleud, Belgium. ^[5] GSK, Via Fiorentina 1, 53100, Siena, Italy. ^[6] UCB Pharma, 208 Bath Road, Slough, SL1 3WE, Berkshire, UK. ^[7] AstraZeneca, Chemical Development, Pharmaceutical Technology and Development, Operations, Charter Way, Macclesfield, Macclesfield, SK10 2NA, UK. ^[8] Amgen, 4, Uxbridge Business Park, Sanderson Road, Uxbridge, UB8 1DH, UK. ^[9] Pfizer Ltd., Walton Oaks, Dorking Road, Tadworth, KT20 7NS, Surrey, UK. ^[10] Merck & Co., Inc., 770 Sumneytown Pike, West Point, PA, 19486, USA. ganapathy_mohan@merck.com. ^[11] Eli Lilly Kinsale Ltd, Dunderrow, Kinsale, P17 NY71, Co. Cork, Ireland. ^[12]